Oncoclínicas do Brasil Serviços Médicos (ONCO3) reported in a market announcement on Tuesday, October 27, 2026, that it is not a party to the case pending before the 21st Federal Civil Court of São Paulo which, according to a report by the newspaper Valor Econômico on October 23, 2026, is said to have granted an injunction suspending the immediate obligation to launch the company’s public tender offer (OPA) for its shares, estimated by the article at up to R$ 14 billion.
The company also stated that, to date, it has neither become aware of nor been formally notified about the mentioned injunction, having learned of the case and the alleged suspension of the tender offer only through reports in the press.
According to the statement, Oncoclínicas said it does not have additional information about the case or about the decision to suspend the tender offer, as these matters relate to its shareholders, and it reiterated its commitment to keep the market informed whenever there are material facts related to the topic.
